T1	Participants 49 84	severely immunocompromised patients
T2	Participants 245 373	varicella-zoster virus infection in severely immunocompromised patients who presented within 72 hours of onset of the infection.
T3	Participants 374 416	Eleven patients were treated in each group
T4	Participants 1306 1332	immunocompromised patients
